FSA goes Gaga over breast milk ice cream...
The Food Standards Agency (FSA) is investigating whether a controversial ice cream made with donated breast milk, and sold in a London restaurant, breaches food safety regulations.
Archives for March 1, 2011
Raisio meta-analysis backs high-dose stanols for cholesterol reduction
Intakes of stanols in excess of the recommended 2 grams per day dose are associated with additional and dose-dependent reductions in LDL-cholesterol, according to a new meta-analysis of over 110 trials.
Nutrigenomics shows benefit of magnesium’s metabolic actions
Magnesium’s favorable effects on certain metabolic pathways is associated with changes in gene expression, says a new study that adds to our knowledge of nutrigenomics.
The balancing act of allergen labelling
The food industry has a responsibility to label allergenic ingredients as big and bold as they can – but also not to over-egg the slimmest of slim possibilities that a trace amount of an allergen may have slipped into a product.
AAK sets up shop in China
Fats and oil specialist AAK has opened a new office in China and appointed a new country manager, in a bid to get closer to its local customers.
Probiotic academics turn up political health claim heat
A recently established group of global gut health academics is sending letters to Members of the European Parliament (MEPs) as well as national government politicians as the group attempts to alter the application of a regulation it says is, “killing the...
Danone demands EFSA reveal “minority opinions” in Actimel health claim rejection response
Global probiotics leader Danone has written a 14-page response to the European Food Safety Authority (EFSA) in which it accuses the Parma-based agency of ignoring positive trial data and demands to see “minority opinions” among health claim panel decisions.
Chr Hansen collaborates for children’s nutrition in Vietnam
Chr Hansen has teamed up with Vietnamese dairy giant Vinamilk to develop bio science-based nutritional products for children – with the first product, containing BB-12 and LLG cultures due for launch.